Peer Review History

Original SubmissionApril 8, 2025
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Natasha Shaukat, Editor

Dear Dr. O'Connor,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Natasha Shaukat

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB

3. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [A preliminary version of this manuscript was uploaded to the preprint service MedRXIV.] Please clarify whether this conference proceeding or publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

4. Thank you for stating the following financial disclosure: [This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR00145]. 

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. We notice that your supplementary file are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please see reviewers comments at the end.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Congratulations to the authors on their well-conducted and insightful research.

The authors used the Theoretical Framework of Acceptability (TFA) and the Fogg Behavior Model (FBM) to guide their data collection and analysis, which was apt. The study brings important insights into what matters most to people living with COPD.

There are several notable strengths. The methodological rigor is further demonstrated through high inter-coder reliability (Krippendorff’s alpha of 0.86) and evidence of thematic saturation. The qualitative data are rich, and the authors clearly present their findings, supported by explanatory participant quotes.

There are, however, a few areas where the manuscript could be improved:

• The FBM mapping is not presented visually. Maybe if the authors couldinclude a figure or some form that illustrates this would help readers better understand how the model was applied.

• the manuscript does not provide sufficient detail about who the caregivers are—for example, their relationship to the patient, or the intensity of their caregiving roles. A table or brief summary of this information would be useful.

• The study is based in a single region and includes a sample that appears to be largely White and digitally literate. The limitations section should more clearly acknowledge how this may affect the generalisability of the findings to other populations, particularly those from more diverse or underserved backgrounds..

• It would be helpful if the authors briefly described in the Methods section how the interview guide evolved after piloting.

• The manuscript mentions participant personas as separate illustrations in the supplementary materials. It would be good to clarify if these were developed solely for internal understanding or were intended for dissemination or further use.

• The authors have done an excellent job of centering patient and caregiver voices in their exploration of COPD clinical research. With a few minor revisions to improve clarity and transparency, I believe this manuscript will make a valuable addition to the literature.

Reviewer #2: This research explored what matters most to patients with COPD in order to better align COPD research with their real-life needs and experiences. This is a timely and interesting study. I have a few comments:

1. Did you consider the occupation of the participants? Or income? It should have a significant impact on understanding the patient’s needs/perception.

2. Can you please comment on the response rate?

3. Prior understanding/research of this topic is not well discussed.

4. In the discussion, it will be impactful to have discussions of possible barriers to addressing the patient’s needs and how to address these issues in real life.

5. Did you consider the subgroup-level analysis? (for example: by gender)

6. Did you consider key informant interviews? It can guide future implementation of research findings.

Relevant articles:

Sigurgeirsdottir, J., Halldorsdottir, S., Arnardottir, R. H., Gudmundsson, G., & Bjornsson, E. H. (2019). COPD patients' experiences, self-reported needs, and needs-driven strategies to cope with self-management. International journal of chronic obstructive pulmonary disease, 14, 1033–1043. https://doi.org/10.2147/COPD.S201068

Poletti, V., Bresciani, G., Banfi, P., & Volpato, E. (2024). Exploring perceptions and expectations of COPD patients: A grounded theory approach for personalized therapeutic interventions. Chronic respiratory disease, 21, 14799731241268262. https://doi.org/10.1177/14799731241268262

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Dr. Adrija Roy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

June 4, 2025

Dear Dr. Shaukat,

We sincerely appreciate your time and expertise, and that of our reviewers. We are grateful for their thoughtful, critical reviews and believe that responding to their suggestions has significantly strengthened the manuscript.

Below, please find a line-by-line response to the reviewers’ comments and the revisions made in response to their suggestions. For clarity, the authors’ responses and actions taken have been bolded. We hope that you find the manuscript substantially improved and suitable for publication.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Author Response: The authors understand the importance of formatting the manuscript in the style of PLOS ONE.

Action Taken: The manuscript has been carefully revised to comply with all PLOS ONE’s formatting requirements.

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB

Author Response: The authors agree that further clarification of our consent process is needed. Because the study is considered less than minimal risk by the authorizing IRB (entailing only activities that would not require written consent outside of the research context), verbal consent was allowed. Per our institutional protocol, a written Fact Sheet was provided to all participants to read and review before deciding to consent and begin study activities. The participant was then allowed to provide verbal consent witnessed by at least one additional study team member, and the interview proceeded. The verbal consent was documented on the cover sheet of each participant’s interview notes. This process was authorized by the supervising IRB of record.

Action Taken: The methods section of the manuscript was revised to note that all participants were provided with a written Fact Sheet at the time of recruitment and provided fully informed verbal consent to a member of the study team. A second member of the study team witnessed the consent before the start of the interview. The consent process and participant-facing Fact Sheet were approved under the authorizing IRB and complied with all relevant ethical regulations, including the Declaration of Helsinki.

3. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [A preliminary version of this manuscript was uploaded to the preprint service MedRXIV.] Please clarify whether this conference proceeding or publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

Author Response: The authors note that the manuscript has been uploaded to a preprint server (MedRVIX), but it has not been formally peer-reviewed, formally published, or presented at an academic conference and therefore this submission does not constitute dual publication.

Action Taken: The submission details and cover letter have been updated to note that A preliminary version of this manuscript was submitted to the preprint service MedRVIX, but it has not been formally peer-reviewed, published, or presented at an academic conference.

4. Thank you for stating the following financial disclosure: [This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR00145].

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Author Response: The authors agree with the editor that it is important to clarify the role of funders in any research project.

Action Taken: The cover letter has been revised to note that the project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grants KL2TR001454 and UL1-TR001453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

5. We notice that your supplementary file are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

Author Response: The authors regret this error

Action Taken: The supplemental file has been reuploaded in the appropriate section in the submission portal.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Author Response: The citations have been thoroughly reviewed and are correct and complete. In response to one of the reviewers’ feedback, we have added two additional references, which are discussed below.

Action Taken: Two additional references were added at the suggestion of a reviewer. No references were removed.

Reviewers' comments:

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Author Response: The authors are glad that the reviewers found the manuscript technically sound.

Action Taken: No action taken

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

Author Response: There was no statistical analysis performed for this qualitative study.

Action Taken: No action taken

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Author Response: The authors are glad that the reviewers believe that the findings were fully available

Action Taken: No action taken

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Author Response: The authors are glad that the reviewers feel that the manuscript was written in an intelligible fashion

Action Taken: No action taken

5. Review Comments to the Author

Reviewer #1: Congratulations to the authors on their well-conducted and insightful research.

The authors used the Theoretical Framework of Acceptability (TFA) and the Fogg Behavior Model (FBM) to guide their data collection and analysis, which was apt. The study brings important insights into what matters most to people living with COPD. There are several notable strengths. The methodological rigor is further demonstrated through high inter-coder reliability (Krippendorff’s alpha of 0.86) and evidence of thematic saturation. The qualitative data are rich, and the authors clearly present their findings, supported by explanatory participant quotes.

Author Response: The authors are glad that the reviewer found the manuscript rigorous and insightful

Action Taken: No action taken

There are, however, a few areas where the manuscript could be improved:

• The FBM mapping is not presented visually. Maybe if the authors could include a figure or some form that illustrates this would help readers better understand how the model was applied.

Author Response: The authors agree that further explanation of how the FBM model was applied, and how the results were interpreted, would be helpful in the manuscript

Action Taken: Additional interpretation of the application of the FBM was added to the discussion. Additionally, we have added “Figure 1”, depicting the mapping of each participant onto an FBM graph to provide readers with an illustration of the results.

• the manuscript does not provide sufficient detail about who the caregivers are—for example, their relationship to the patient, or the intensity of their caregiving roles. A table or brief summary of this information would be useful.

Author Response: The authors agree that additional information about the caretakers included in the study would be helpful.

Action Taken: A brief summary of the two caretaker participants’ relationship and role with respect to a patient living with COPD was added to the beginning of the results section.

• The study is based in a single region and includes a sample that appears to be largely White and digitally literate. The limitations section should more clearly acknowledge how this may affect the generalisability of the findings to other populations, particularly those from more diverse or underserved backgrounds..

Author Response: The authors agree with the reviewer that the relatively homogenous sample represented in this study may limit generalizability to the larger population of patients living with COPD.

Action Taken: Additional language was added to the limitations, highlighting that the small, relatively homogenous sample represented in this study may not be generalizable to the entire population of patients living with COPD and that further study specifically evaluating the perspectives of populations underrepresented in research is warranted.

• It would be helpful if the authors briefly described in the Methods section how the interview guide evolved after piloting.

Author Response: The authors agree with the reviewer that a description of the interview guide modification process would help readers understand the methodological approach to this study.

Action Taken: A description of how and when the interview guide was modified was added to the methods section of the paper.

• The manuscript mentions participant personas as separate illustrations in the supplementary materials. It would be good to clarify if these were developed solely for internal understanding or were intended for dissemination or further use.

Author Response: The reviewer asks a good question. The personas developed during the study were for internal use only to spark discussion and guide future patient-centered study design. However, we also felt that they would be of interest to readers and therefore were shared as a supplemental file.

Action Taken: The methods were revised to specifically note that the personas were developed to internally guide future study design.

The authors have done an excellent job of centering patient and caregiver voices in their exploration of COPD clinical research. With a few minor revisions to improve clarity and transparency, I believe this manuscript will make a valuable addition to the literature.

Author Response: The authors are glad that the reviewer feels that this manuscript will make a meaningful contribution to the literature

Action Taken: No action taken

Reviewer #2: This research explored what matters most to patients with COPD in order to better align COPD research with their real-life needs and experiences. This is a timely and interesting study. I have a few comments:

Author Response: The authors are gratified that the reviewer found the manuscript relevant and interesting.

Action Taken: No action taken

1. Did you consider the occupation of the participants? Or income? It should have a significant impact on understanding the patient’s needs/perception.

Author Response: We did not track the income or occupation of the participants. The authors agree with the reviewer that these factors impact patients’ perspectives and that not reporting on them may limit generalizability to the larger population of patients living with COPD.

Action Taken: Additional language was added to the limitations, highlighting that the small, relatively homogenous sample represented in this study, as well as the fact that occupation and SES was not reported on, may result in a sample whose perspective is not generalizable to the entire population of patients living with COPD and that further study specifically evaluating the perspectives of populations underrepresented in research is warranted.

2. Can you please comment on the response rate?

Author Response: The authors agree with the reviewer that a comment on the response rate would be appropriate in the discussion of this paper. Some participants’ contact information may have been incorrect or out of date, some participants may not be comfortable participating in an interview or using teleconferencing software. We should acknowledge that the response rate

Action Taken: The authors added a brief discussion of the modest participant response rate and the possibility of resultant sampling bias to the limitations of the paper.

3. Prior understanding/research of this topic is not well discussed.

Author Response: The authors agree with the reviewer that a discussion of prior research exploring this topic was modest in the discussion, and the paper would benefit from additional examination. We are grateful for the suggested citations.

Action Taken: The authors added a more robust assessment of the prior literature on the topic of patient priorities in COPD, and compared it to our findings.

4. In the discussion, it will be impactful to have discussions of possible barriers to addressing the patient’s needs and how to address these issues in real life.

Author Response: The authors agree that discussing the barriers to patient preferences in more detail would be interesting and important for readers. We did discuss some of the barriers and solutions to real-time data sharing, but agree that we should expand this approach to the study’s other major findings.

Action Taken: The authors added exploration of the barriers and solutions to addressing patient preferences in COPD research to the project’s discussion.

5. Did you consider the subgroup-level analysis? (for example: by gender)

Author Response: The authors agree with the reviewer that a subgroup analysis of patient perspectives by discrete demographic features would be relevant and interesting. However, as this was a qualitative study, our goal was to explore the depth and range of participant experiences rather than to compare groups. Given the sample size and the exploratory nature of the study, we prioritized thematic saturation and var

Attachments
Attachment
Submitted filename: Response to Reviewer Document.docx
Decision Letter - Natasha Shaukat, Editor

“A Good Day Is Just Being Able to Breathe": Aligning COPD Research with Patient Needs, a Qualitative Study

PONE-D-25-18562R1

Dear Dr. Connor ,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Natasha Shaukat

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: Thank you for addressing all the comments. The manuscript is now okay for publication from my end. Accepted.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Adrija Roy

**********

Formally Accepted
Acceptance Letter - Natasha Shaukat, Editor

PONE-D-25-18562R1

PLOS ONE

Dear Dr. O'Connor,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Natasha Shaukat

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .